D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 38 Citations 8,431 111 World Ranking 5146 National Ranking 2250

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Pathology

Pathology, Amyloid, Positron emission tomography, Alzheimer's disease and Internal medicine are his primary areas of study. His work carried out in the field of Pathology brings together such families of science as Episodic memory and Cognitive test. His Alzheimer's disease study combines topics in areas such as Dementia and Nuclear medicine.

Michael J. Pontecorvo connects Nuclear medicine with Amyloid pathology in his research. His Internal medicine research incorporates elements of Standardized uptake value, Cognition and Cardiology. His Amyloid β research includes themes of Radiology, Pet imaging, Neuropathology, Prospective cohort study and Autopsy.

His most cited work include:

  • Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (504 citations)
  • The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET (273 citations)
  • Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods (255 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Pathology, Amyloid, Nuclear medicine, Disease and Positron emission tomography. When carried out as part of a general Pathology research project, his work on Dementia, Autopsy, Dementia with Lewy bodies and Amyloid pet is frequently linked to work in Chemistry, therefore connecting diverse disciplines of study. Michael J. Pontecorvo combines subjects such as Radiology, Cognition and Atrophy with his study of Amyloid.

His work on Pet imaging is typically connected to Test retest reproducibility as part of general Nuclear medicine study, connecting several disciplines of science. In general Disease study, his work on Cognitive impairment and Solanezumab often relates to the realm of Clinical diagnosis, thereby connecting several areas of interest. His studies deal with areas such as Alzheimer's disease, Effective dose and Cognitive decline as well as Positron emission tomography.

He most often published in these fields:

  • Pathology (30.36%)
  • Amyloid (29.46%)
  • Nuclear medicine (26.79%)

What were the highlights of his more recent work (between 2017-2021)?

  • Nuclear medicine (26.79%)
  • Pathology (30.36%)
  • Internal medicine (20.54%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Nuclear medicine, Pathology, Internal medicine, Disease and Dementia. His work in the fields of Nuclear medicine, such as Pet imaging, intersects with other areas such as Phase. His research in the fields of Autopsy and Amyloid overlaps with other disciplines such as Basal ganglia.

His research investigates the link between Disease and topics such as Cognition that cross with problems in National Adult Reading Test. His Dementia research is multidisciplinary, incorporating elements of Neuropathology and Pathological. His work in Neuropathology tackles topics such as Stage which are related to areas like Positron emission tomography.

Between 2017 and 2021, his most popular works were:

  • A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia. (62 citations)
  • Tau Positron-Emission Tomography in Former National Football League Players (60 citations)
  • Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes (55 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Alzheimer's disease
  • Pathology

Michael J. Pontecorvo spends much of his time researching Positron emission tomography, Nuclear medicine, Standardized uptake value, Alzheimer's disease and Dementia. His research brings together the fields of Psychiatry and Positron emission tomography. His Nuclear medicine research includes themes of Pittsburgh compound B, Magnetic resonance imaging, Brain size, Disease and Amyloid burden.

His Standardized uptake value study combines topics in areas such as Longitudinal study, Cardiology, Effects of sleep deprivation on cognitive performance, Cognition and Neuropsychological test. The study incorporates disciplines such as Volumetric magnetic resonance imaging, Atrophy, Cohort and Autopsy in addition to Alzheimer's disease. His Dementia study improves the overall literature in Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Christopher M. Clark;Julie A. Schneider;Barry J. Bedell;Thomas G. Beach.
JAMA (2011)

1105 Citations

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Christopher M Clark;Michael J Pontecorvo;Thomas G Beach;Barry J Bedell.
Lancet Neurology (2012)

708 Citations

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

William E. Klunk;William E. Klunk;Robert A. Koeppe;Julie C. Price;Tammie L. Benzinger;Tammie L. Benzinger.
Alzheimers & Dementia (2015)

477 Citations

Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects

Abhinay D. Joshi;Michael J. Pontecorvo;Chrisopher M. Clark;Alan P. Carpenter.
The Journal of Nuclear Medicine (2012)

404 Citations

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Eric R. Siemers;Karen L. Sundell;Christopher Carlson;Michael Case.
Alzheimers & Dementia (2016)

398 Citations

Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

Susan M. Landau;Susan M. Landau;Susan M. Landau;Christopher Breault;Abhinay D. Joshi;Michael Pontecorvo.
The Journal of Nuclear Medicine (2013)

378 Citations

Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease

Adam S. Fleisher;Kewei Chen;Xiaofen Liu;Auttawut Roontiva.
JAMA Neurology (2011)

349 Citations

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.

Susan M. Landau;Susan M. Landau;Ming Lu;Abhinay D. Joshi;Michael Pontecorvo.
Annals of Neurology (2013)

304 Citations

Individual differences in aging: Behavioral and neurobiological correlates

Alicja L. Markowska;William S. Stone;Donald K. Ingram;Jay Reynolds.
Neurobiology of Aging (1989)

279 Citations

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Michael J. Pontecorvo;Michael D. Devous;Michael Navitsky;Ming Lu.
Brain (2017)

244 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael J. Pontecorvo

William J. Jagust

William J. Jagust

University of California, Berkeley

Publications: 135

Victor L. Villemagne

Victor L. Villemagne

University of Pittsburgh

Publications: 134

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 131

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 108

Christopher C. Rowe

Christopher C. Rowe

University of Melbourne

Publications: 103

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 99

Alzheimer's Disease Neuroimaging Initiative

Alzheimer's Disease Neuroimaging Initiative

University of North Carolina at Chapel Hill

Publications: 97

Rik Ossenkoppele

Rik Ossenkoppele

Lund University

Publications: 87

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 84

Philip Scheltens

Philip Scheltens

Amsterdam UMC

Publications: 80

Agneta Nordberg

Agneta Nordberg

Karolinska University Hospital

Publications: 76

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 76

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 75

Michael W. Weiner

Michael W. Weiner

University of California, San Francisco

Publications: 68

Ralph N. Martins

Ralph N. Martins

Edith Cowan University

Publications: 66

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 61

Trending Scientists

David Levin

David Levin

Tel Aviv University

Bruce C. Berndt

Bruce C. Berndt

University of Illinois at Urbana-Champaign

Constantinos V. Chrysikopoulos

Constantinos V. Chrysikopoulos

Technical University of Crete

Konstantin S. Novoselov

Konstantin S. Novoselov

University of Manchester

William M. Nauseef

William M. Nauseef

University of Iowa

Susana Merino

Susana Merino

University of Barcelona

Jeffrey W. Hedenquist

Jeffrey W. Hedenquist

University of Ottawa

Brian Kendall

Brian Kendall

University of Waterloo

Dean C. Presnall

Dean C. Presnall

The University of Texas at Dallas

Giovanni Picardi

Giovanni Picardi

Sapienza University of Rome

Susanne V. Hering

Susanne V. Hering

Aerosol Dynamics (United States)

Tatsuya Mima

Tatsuya Mima

Ritsumeikan University

Andreas S. Tolias

Andreas S. Tolias

Baylor College of Medicine

Craig R. Colder

Craig R. Colder

University at Buffalo, State University of New York

Larry W. Hawk

Larry W. Hawk

University at Buffalo, State University of New York

Axel Hauschild

Axel Hauschild

Kiel University

Something went wrong. Please try again later.